Qatar Diabetes Mobile Application Trial

NAUnknownINTERVENTIONAL
Enrollment

180

Participants

Timeline

Start Date

August 22, 2019

Primary Completion Date

August 17, 2020

Study Completion Date

December 31, 2020

Conditions
Type2 Diabetes Mellitus
Interventions
DEVICE

Droobi

A new mobile application, specifically built for the diabetes patients in Qatar with the help of local expertise.

OTHER

Standard of care

Standard of care including physicians, dietetics and diabetes educators support

Trial Locations (1)

Unknown

RECRUITING

Hamad General Hospital, Doha

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Qatar Computing Research Institute (QCRI)

UNKNOWN

collaborator

Droobi Health

UNKNOWN

lead

Hamad Medical Corporation

INDUSTRY

NCT03998267 - Qatar Diabetes Mobile Application Trial | Biotech Hunter | Biotech Hunter